StocksMediumUpdated•Originally published 21 October 2026•Updated 21 October 2026•
1 min read
Abbott to Spin Off Nutrition Business and Lowers 2026 Sales Forecast
Key Facts
1Abbott reported third-quarter sales growth of 14.5 percent.
2Adjusted diluted EPS reached $1.42 for the third quarter with reaffirmed full-year guidance.
Abbott announced a plan to separate its nutrition business, which generates $8.5 billion in annual sales, into an independent entity. The company also lowered its 2026 sales growth forecast, citing weakness in the medical device market.
The company reported third-quarter sales growth of 14.5 percent and adjusted EPS of $1.42 for 2026. ABT closed at $102.45 on October 20, 2026, prior to the announcement of these strategic shifts which included a 7.0 percent increase in comparable sales.